ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 8, August 2025 | pp. 579–585
DOI: 10.46882/AJIDR/148846
Article Type: Original Article
Title: Virological suppression, HIV-1 drug resistance mutations, and adherence correlates among adolescents on dolutegravir-based antiretroviral therapy
Names of Authors: Tendai Chikwanda¹*, Jonathan Miller², Mei-Ling Wong³
Authors’ Affiliations: ¹Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe. ²Department of Medicine, University of California San Francisco, San Francisco, United States. ³Department of Microbiology, University of Hong Kong, Hong Kong, China.
Abstract: Sustaining durable virological suppression among adolescents living with HIV remains critical to preventing disease progression and drug resistance emergence. We evaluated viral load outcomes and integrase strand transfer inhibitor resistance mutations among adolescents receiving tenofovir, lamivudine, and dolutegravir. Plasma samples from 490 adolescents on therapy for at least 12 months underwent HIV-1 RNA quantification and Sanger sequencing of the integrase region for viremic participants. Overall viral suppression below 1,000 copies per milliliter was 86.5 percent, with major integrase mutations such as R263K detected in 6.1 percent of viremic individuals. Enhanced peer-led adherence support and targeted resistance testing are essential.
Keywords: HIV-1, Dolutegravir, Drug resistance mutations, Adolescents, Virological suppression
Citation: Chikwanda T, Miller J, Wong M (2025). Virological suppression, HIV-1 drug resistance mutations, and adherence correlates among adolescents on dolutegravir-based antiretroviral therapy. African Journal of Infectious Diseases Research, 12(8): 579–585. DOI: 10.46882/AJIDR/148846
Manuscript Timeline: Received: June 30, 2025; Revised: July 30, 2025; Accepted: August 11, 2025; Published: August 19, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read